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Prenatal Diagnosis of Craniomaxillofacial Malformations: A Characterization
of Phenotypes in Trisomies 13, 18, and 21 by Ultrasound and Pathology
A.M. Ettema, M.D., Ph.D., M. Wenghoefer, M.D., D.M.D., M. Hansmann, M.D., Ph.D., C.E.L. Carels, D.M.D., Ph.D.,
W.A. Borstlap, M.D., D.M.D., Ph.D., S.J. Berge´, M.D., D.M.D., Ph.D.
Objective: To determine the relationship between trisomies 13, 18, and 21 and
craniofacial malformations detected by prenatal sonography.
Design: During a 29-year period (1976 through 2004), prenatal sonographic
findings of 69 fetuses with trisomy 13; 171 fetuses with trisomy 18; 302 fetuses
with trisomy 21; and 17 fetuses with other trisomies were evaluated
retrospectively, after fetal karyotype identification. Sonographic findings were
compared with autopsy results in 209 patients (trisomy 13, n = 39; trisomy 18,
n = 64; and trisomy 21, n = 106).
Results: For trisomy 13, cleft deformities were detected prenatally in 65.2%,
and of the 39 cases with pathological information, 76.9% were found to have a
cleft deformity. Ocular and orbital abnormalities were found in 28%. Malforma-
tions of the jaws and abnormal profiles were more frequently diagnosed
postnatally than prenatally. For trisomy 18, abnormal profiles (41.5%) and ear
abnormalities (5.3%) were the most noticeable ultrasound markers, next to
abnormalities of the neurocranium (36.8%) and cranial bone configuration
(21.6%). Dysmorphisms of the eye, ear, or nose were detected more frequently
in autopsy cases. For trisomy 21, ultrasound showed an aberrant shape of the
skull in 14.2% of fetuses. In general, the ocular-orbital and nasal abnormalities
in fetuses with trisomy 18 or 21 were more evident in pathological examination
than in prenatal ultrasound imaging.
Conclusions: Facial anomalies are common in the major trisomies, and their
prenatal sonographic identification should be improved. The above-mentioned
facial anomalies provide sufficient reason to consider performing cytogenic
evaluation.
KEY WORDS: facial malformations, fetal aneuploidy, prenatal sonography,
trisomy
Trisomies 21, 18, and 13 are the most commonly
diagnosed autosomal trisomies in liveborn infants. Al-
though these conditions are associated with a high degree
of infant mortality, longer survival, especially in the case of
trisomy 21, is quite common nowadays (Rasmussen et al.,
2003).
Each trisomic condition has a typical phenotype that
nevertheless shows a wide variation in phenotypic expres-
sion. However, the face in particular plays an important
role in defining the phenotype. Facial abnormalities are, for
example, quite common among fetuses with trisomy 21. In
2002, Sonek and Nicolaides reported three cases of trisomy
21 with an absence of or shorter nasal bone than would be
expected for the gestational age (Sonek and Nicolaides,
2002). Trisomy 18 is associated with typical facial
abnormalities such as short ear length, an abnormal
profile, micrognathia, and hypotelorism (Yeo et al.,
2003). Also, facial abnormalities due to holoprosencephaly
as well as different types of facial clefts as typical signs of
trisomy 13 have been described (Nicolaides et al., 1993b;
Nyberg and Souter, 2001). With the improving quality of
ultrasound equipment and standards of scanning, cranio-
facial dysmorphisms are more likely to be detected, even by
routine ultrasound examination.
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The aim of this study was to determine the relationship
between major trisomic conditions and prenatally detected
craniofacial malformations.
PATIENTS AND METHODS
The patients were recruited at the Department of
Obstetrics and Gynecology, Division of Prenatal Diagnosis
and Therapy in a Level III hospital from 1976 through
2004. During the study period, 559 fetuses with trisomies 21
(n 5 302), 18 (n 5 171), 13 (n 5 69), and others (n 5 17)
were evaluated sonographically according to an index of
facial and cranial markers for detecting trisomies (Table 1).
Postnatal autopsies were performed in a subset of 209
fetuses. All the cytogenetic and ultrasound records of these
fetuses were reviewed and analyzed retrospectively. In the
first years of the study, besides sonographic examination,
the patients underwent an amniocentesis between gesta-
tional weeks 12 and 39 in order to determine the fetal
karyotype. Since 1987, the techniques of cordocentesis and
placental biopsy also have been used.
Examination of the fetal face was done by a transab-
dominal ultrasound technique and performed by well-
trained obstetricians. Different types of ultrasound systems
equipped with different transducers were used (e.g., the
Sonoline SL 1 and 2 [Siemens AG, Erlangen, Germany];
Acuson 128 [3.5-MHz linear-array transducer], Acuson
Aspen [5- to 7-MHz variable-focus transducer], and
Acuson Sequoia 512 [5- to 8-MHz sector probes, linear;
Acuson Corp., Mountain View, CA]; color doppler
ultrasound HDI 5000 [Philips, type ATL, Bothell, WA];
Kretz Combison 530 D [5.0-MHz annular array transduc-
er; Kretztechnik, Zipf, Austria]; Examination of the face
always included the midsagittal view for profile analysis
and serial axial scans at the level of the forehead, eyes, nose,
and upper and lower lips (Hansmann et al., 1991).
The sonograms (usually reports, videotapes, digital data
media, and thermal prints) of each case were evaluated for
the nature of facial dysmorphism and associated anomalies.
If the circumference of the head was below the fifth
percentile for the corresponding gestational age, micro-
cephaly was diagnosed. The diagnosis of hydrocephalus
was based on an evaluation of the posterior horn of a
lateral ventricle. Nuchal edema of more than 3 mm in the
first trimester was regarded as pathological, and, in the case
of profound retrognathia, the diagnosis of micrognathia
was made without precise measurements. Positioning of the
tongue between the lips during most of the time of the
ultrasound examination was regarded as macroglossia.
In the case of microphthalmia, the diameter of the eye
was smaller than reference values (Hansmann et al., 1991).
Hypotelorism was defined as a decreased interocular
distance of more than one diameter of the orbita.
The data were obtained by review of the charts,
sonograms, and pathological and cytogenetic records.
Sonographic data were compared with the autopsy data
in case of interruption or neonatal death or with the
postnatal clinical findings and detailed information ob-
tained from medical records of the newborn child.
This protocol was approved by our institutional review
board, and informed consent was obtained from each patient.
RESULTS
In cases of fetal trisomy, 69 fetuses with trisomy 13
(12.3%); 171 fetuses with trisomy 18 (30.6%); and 302
fetuses with trisomy 21 (54.0%) were found. Seventeen
cases (3.0%) showed other, less common trisomies. Thirty-
six, 259, and 264 fetuses were scanned in the periods 1976
through 1983, 1984 through 1992, and 1993 through 2004,
respectively. The median gestational age at the time of
sonographic examination was 22 (range, 12 to 35) weeks.
The mean 6 SD maternal age was 33 6 5 years for trisomy
13; 32 6 6 years for trisomy 18; and 36 6 5 years for
trisomy 21.
Trisomy 13 (n = 69)
On detailed ultrasonographic examination, 20 of the 69
fetuses with trisomy 13 showed abnormalities of the shape of
the skull such as microcephaly (n5 10, 14.5%), brachyceph-
aly (n5 9, 13.0%), or a strawberry-shaped head (n5 4, 5.8%).
In 28 cases (40.6%) an abnormal neurocranium was detected,
together with holoprosencephaly (n 5 16, 23.2%) or
hydrocephalus (n5 13, 18.8%) (Table 2).
Eighteen fetuses had a flat profile (26.1%), and eight
fetuses (11.6%) showed micrognathia. Facial clefts were
observed in 45 cases (65.2%), with a predominance of cleft
lip and palate in 36 fetuses (52.2%). Sonographic examina-
tion revealed ocular and orbital abnormalities in 21 fetuses,
most frequently microphthalmia (n 5 15, 21.7%), followed
by hypotelorism and hypertelorism (n 5 4, 5.8% each).
Using ultrasound only, nasal defects were detected in 13.0%
(n 5 9) and ear malformations in 4.3% (n 5 3) (Table 3).
Among the 39 fetuses with trisomy 13 in which an
autopsy was performed, 33.3% (n 5 13) had an abnormal
TABLE 1 Screening Index of Markers for Detecting Trisomies 13,
18, and 21
Abnormal skull Facial clefts, cleft lip, or cleft palate
Macrocephaly or microcephaly Median cleft
Brachycephaly Microstomia
Strawberry skull Ocular or orbital abnormalities
Polyhydramnion* Anophthalmia
Abnormal neurocranium Microphthalmia
Holoprosencephaly Hypotelorism or hypertelorism
Hydrocephalus Nasal abnormalities
Choroid plexus cysts Single nostril
Nuchal edema or translucency No nasal bone
Facial defects Ear abnormalities
Flat forehead Retrocaudal positioning of the ears
Flat or abnormal profile Low-set ears or small ears
Micrognathia Cardiac abnormality*
Macroglossia
* Not included in this study.
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shape of the skull, and 25.6% (n 5 10) had holoprosence-
phaly. High incidences of flat profile (n 5 29, 74.4%) and
facial clefts (n 5 30, 76.9%) were found, including 23
(59.0%) fetuses with cleft lip and palate. Ocular-orbital and
nasal abnormalities were each found in 11 fetuses (28.2%)
and ear malformations were found in five (12.8%).
Trisomy 18 (n = 171)
Thirty-seven fetuses with trisomy 18 (21.6%) showed
abnormalities of the shape of the skull, including brachy-
cephaly (n 5 17, 9.9%), strawberry-shaped skull (n 5 14,
8.2%), and microcephaly (n 5 9, 5.3%).
The incidence of a flat profile was 41.5% (n5 71), clearly
more frequent (p5 .025, x2 test) than in trisomy 13 (26.1%)
(Tables 2 and 3). Sonographic micrognathia was found in
35 fetuses (20.5%). Thirteen (7.6%) of the fetuses were
suspected prenatally to have a cleft lip and palate, whereas
ocular (n 5 7, 4.1%), nasal (n 5 5, 2.9%), and ear
abnormalities (n 5 9, 5.3%) were rarely found.
Among the 64 fetuses (37.4%) who underwent autopsy,
33 (51.6%) showed abnormalities of the shape of the skull,
and 28 (43.8%) had an abnormal profile; 10 fetuses (15.6%)
presented with a flat forehead, and 17 (26.6%) showed a
vertical forehead. A flat occiput was described in 15.6% (n
5 10). Fetal cleft lip and palate was identified postnatally in
19 fetuses (29.7%) (Table 3). In contrast with ultrasound
findings, 48 fetuses (75.0%) showed abnormal anatomical
ocular and orbital findings. Forty-seven fetuses (73.4%)
were diagnosed with ear malformation, and 41 fetuses
(64.1%) with nasal malformation. Autopsy data revealed
micrognathia in 32 fetuses (50%); whereas, microstomia
was diagnosed in 27 cases (42.2%).
Trisomy 21 (n = 302)
Brachycephaly was diagnosed prenatally in 42 fetuses
(13.9%). Besides a flat profile in 29.1% (n 5 88), nuchal
edema (n 5 69, 22.8%) was a frequent marker for trisomy
21. Sonographically detected ocular-orbital abnormalities
and nasal malformations were rare, with 13 occurrences
(4.3%) each, and ear malformations (n5 1, 0.3%) were very
rare. Macroglossia (n 5 7) and micrognathia (n 5 7) were
observed ultrasonographically in 2.3% of the fetuses and
facial clefts in 1% (n 5 3).
Pathological and postnatal clinical examination (n 5
106, 35.1%) revealed an abnormally shaped skull in 81 cases
(76.4%), with a majority of brachycephaly (n 5 71, 67.0%).
Fifty-five (51.9%) had a flat profile, 17 (16.0%) microgna-
thia, and 41 (38.7%) macroglossia. Nuchal edema could be
observed in 25 fetuses (23.6%).
In contrast to sonographic indications, evaluation of the
macroscopic anatomy showed a high percentage of ocular-
orbital (n 5 91, 85.8%), nasal (n 5 84, 79.2%), and ear
malformations (n 5 41, 38.7%). Among these malforma-
tions, hypertelorism (n 5 81, 76.4% versus n 5 4, 1.3% inT
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ultrasound) and mongoloid palpebral fissures (n 5 43,
41.7% versus n 5 5, 1.7% in ultrasound) were noted
frequently; whereas, retrocaudally positioned ears (n 5 19,
17.9% versus n 5 0, 0% in ultrasound), low-set ears (n 5
23, 21.7% versus n 5 1, 0.3% in ultrasound), low nasal root
(n 5 19, 18.4% versus n 5 1, 0.3% in ultrasound), and flat
nasal bridge (n 5 39, 37.9% versus n 5 1, 0.3% in
ultrasound) were seen less frequently. An anteversion
nostril (n 5 2, 22.3%) and triangular nostril (n 5 16,
15.5%) were described only in the clinical pathological or
postnatal examination.
In all 209 cases in which information from a pathological
follow-up after ultrasound was available, the comparisons
of the ultrasound diagnosis and pathological results were
analyzed (Table 4). All sonographic findings were com-
pared with the corresponding clinical conditions regarding
accuracy (Fig. 1). One has to take into account that it was
difficult for four reasons to make a clear statement about
FIGURE 1 Comparison of ultrasound diagnosis with pathological follow-up among the 209 fetuses that underwent both, n (%).
TABLE 4 Comparison of Ultrasound Diagnosis With Pathological Result Among the 209 Cases in Which Pathological Follow-Up Information
Was Available*
Finding
False Negative, n
(%)
False Positive, n
(%)
True Negative, n
(%)
True Positive, n
(%)
Sensitivity
(%)
Specificity
(%)
Shape of the skull 41 (19.6) 21 (10.0) 61 (29.2) 86 (41.2) 67.7 74.4
Brachycephaly 71 (34.0) 17 (8.1) 107 (51.2) 14 (6.7) 16.5 86.3
Strawberry skull 1 (0.5) 6 (2.9) 201 (96.1) 1 (0.5) 50.0 97.1
Microcephaly 19 (9.1) 4 (1.9) 182 (87.1) 4 (1.9) 17.4 97.9
Abnormal neurocranium 19 (9.1) 26 (12.4) 135 (64.6) 29 (13.9) 60.4 83.9
Holoprosencephaly 4 (1.9) 2 (1.0) 195 (93.3) 8 (3.8) 66.7 99.0
Hydrocephalus 1 (0.5) 14 (6.7) 192 (91.8) 2 (1.0) 66.7 93.2
Choroid plexus cysts 1 (0.5) 17 (8.1) 187 (89.5) 4 (1.9) 80.0 91.6
Nuchal edema 19 (9.1) 33 (15.8) 145 (69.4) 12 (5.7) 38.7 81.5
Facial defects
Flat profile 70 (33.5) 26 (12.4) 65 (31.1) 48 (23.0) 40.7 71.4
Micrognathia 45 (21.5) 11 (5.3) 146 (69.9) 7 (3.3) 13.5 93.0
Macroglossia 40 (19.1) 1 (0.5) 167 (79.9) 1 (0.5) 2.4 99.4
Facial clefts
Median cleft 5 (2.4) 2 (1.0) 196 (93.7) 6 (2.9) 54.6 99.0
Cleft lip and palate 17 (8.1) 5 (2.4) 154 (73.7) 33 (15.8) 66.0 96.9
Ocular abnormalities
Microphthalmia 9 (4.3) 9 (4.3) 189 (73.7) 2 (1.0) 18.2 95.5
Hypotelorism 5 (2.4) 5 (2.4) 198 (90.4) 1 (0.5) 16.7 97.5
Hypertelorism 126 (60.3) 5 (2.4) 75 (35.9) 3 (1.4) 2.3 93.8
Nasal abnormalities
Minor nasal abnormalities 11 (52.6) 6 (2.9) 89 (42.6) 4 (1.4) 3.5 93.7
Major nasal abnormalities 9 (4.3) 5 (2.4) 192 (91.9) 3 (1.9) 25.0 97.5
Single nostril 0 (0.0) 0 (0.0) 209 (100.0) 0 (0.0) – 100.0
No nasal bone 1 (0.5) 0 (0.0) 172 (82.3) 36 (17.2) 97.3 100.0
Ear abnormalities
Low-set ears 57 (27.3) 1 (0.5) 151 (72.2) 0 (0.0) 0.00 99.3
* – indicates no patient data available.
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sensitivity and specificity. First, not all the women who
were investigated during the study period (approximately
30,000) could be reviewed. Second, because this study
involved a level III hospital, there was already a positive
selection for fetuses at risk. Third, not all sonographic
findings could be compared with postnatal autopsy
results, and fourth, the medical technology experienced
an impressive innovation in the three decades spanned by
the study.
DISCUSSION
Facial dysmorphisms seen in individuals with trisomies
13, 18, or 21 vary considerably. As a result of continuous
advancements in ultrasound techniques, it has become
possible to detect craniofacial malformations as early as the
11th week of gestation. In the literature, the largest
karyotyped series of fetuses with sonographically detected
craniomaxillofacial anomalies included 146 cases (Nico-
laides et al., 1993a). The present study involved 559
trisomic fetuses.
Ocular Abnormalities
Ocular and orbital anomalies have been associated with
several chromosomal abnormalities. According to the
studies by Denis et al. (1993) and Trout et al. (1994), the
inner and outer orbital measurements are useful for
identifying fetuses with chromosomal defects. Similar to
the findings of Nicolaides et al. (1993b), the occurrence of
ocular and orbital pathology (especially microphthalmia
and hypotelorism) was about 30% at sonography as well as
at autopsy in trisomy 13 fetuses (Table 3). In a pathomor-
phological study, Siliaeva (1990) found ocular pathologies
such as dysplasia of the retina, colobomas, cataract, and
luxations of the lens in 25 out of 28 trisomy 13 fetuses
(89.3%). In contrast with the findings between sonography
and autopsy in trisomy 13 fetuses, there was a large
discrepancy between clinical pathology and ultrasound
examination in trisomy 18 and 21 fetuses, with only 70%
(trisomy 18) to 80% (trisomy 21) of the ocular pathology
being demonstrated by ultrasonography in this study.
Nasal Abnormalities
Absence and hypoplasia of the nasal bones have been
proposed recently as important markers for the detection of
trisomy 21 (Bunduki et al., 2003; Vintzileos et al., 2003;
Zoppi et al., 2003). In order to be accurate, this finding
must be assessed using a midsagittal section of the face
(Berge´ et al., 2001). One limitation of our study is that the
assessment of this sonographic marker may not be optimal
because the data were collected over a long period of time,
and a specific effort to examine nasal bones with current
imaging standards was not part of our examination
protocol.
Ear Abnormalities
Abnormally small ears have been described previously in
fetuses with aneuploidy (Birnholz and Farrell, 1988;
Lettieri et al., 1993; Awwad et al., 1994; Yeo et al., 2003).
According to a study by Yeo et al. (2003), a short ear
length—below the 10th percentile for gestational age—was
accepted as a sensitive marker for trisomy 18 (n 5 26/27,
96.3%); whereas, in a study by Chitkara et al. (2002), a
short ear was a negative marker for fetuses with trisomy 18
(n 5 0/4) and a positive marker for 3 out of 19 trisomy 21
fetuses (15.8%). For trisomy 21, this was confirmed by
Vintzileos and Egan (1995) in a prospective study.
In a previous study, low-set ears were found to be one of
the most frequent external anomalies (n 5 24, 77.4%) in
autopsy cases with trisomy 18 (Kinoshita et al., 1989).
Similarly, almost 50% of our trisomy 18 cases were found at
autopsy to have low-set ears.
In trisomy 21 fetuses at 11 to 14 weeks’ gestation, ear
length is reduced; however, the degree of deviation from
normal has been found to be too small for this marker to be
useful in screening for trisomy 21 (Sacchini et al., 2003).
Facial Clefts
In agreement with a previous study, the highest rate of
median clefts revealed by ultrasound was found in fetuses
with trisomy 13 (n 5 8/28, 28.6%) (Berge´ et al., 2001);
whereas, the incidence of cleft lip and palate was quite
uncommon in trisomy 21 (1%) (Lopoo et al., 1999). The
importance of characterizing the type of facial cleft was
demonstrated by Nyberg et al. (1995), indicating that the
type and extension of the cleft correlate with fetal outcome
and karyotype abnormalities. In a study to determine the
correlation between prenatal diagnosis and postnatal
findings, Sohan et al. (2001) could demonstrate that
ultrasound is a useful tool in screening for cleft lip with
or without cleft palate but not for an isolated cleft palate.
Nevertheless, even an isolated case of cleft lip was thought
to be more at risk for a chromosomal abnormality (Nyberg
et al., 1995; Berge´ et al., 2001).
Abnormal Profile/Micrognathia
The facial profile of fetuses with a trisomic condition can
be characterized by an insufficient configuration of the
nose or by micrognathia with markedly receding chin and
an unusually small mandible. Micrognathia occurs second-
ary to abnormalities of the first branchial arch caused by
deficiency or insufficient migration of neural crest cells in
the fourth week of gestation (Mernagh et al., 1999). Besides
trisomies 13 and 18, micrognathia is often part of other
syndromes or sequences, such as Treacher Collins syn-
drome, Goldenhar syndrome, and Seckel or Pierre Robin
sequence (Nicolaides et al., 1993b; Bromley and Benacer-
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raf, 1994). Regarding abnormal profiles, the results of this
study—in which sonographic findings like micrognathia, a
flat profile, and macroglossia are associated with an
abnormal karyotype in 26% to 42% of the fetuses—
correspond with the literature, in which the equivalent
figure is 25% to 40% of fetuses (Benacerraf et al., 1986;
Nicolaides et al., 1993a; Turner and Twining, 1993;
Bromley and Benacerraf, 1994).
Sonographic diagnosis of fetal micrognathia should,
therefore, lead to a further search for evidence of other,
possibly associated anomalies; if positive, determining
karyotype is highly recommended.
In summary, some isolated prenatal sonographic find-
ings, such as facial clefts and profile abnormalities, are not
necessarily indicative of aneuploidy; whereas, multiple
facial abnormalities increase the likelihood of a trisomic
condition (Nicolaides et al., 1992; Nicolaides et al., 1993b;
Nyberg et al., 1993; Lehman et al., 1995; Hill, 1996; Hafner
et al., 1997; Shields et al., 1998; Berge´ et al., 2001). A
detailed facial scan therefore improves the detection of a
trisomy.
In accordance with the literature (Nyberg and Souter,
2001), sonographically detected facial pathology can be
obtained in 90% of fetuses with trisomy 13, in 60% to 80%
of fetuses with trisomy 18, and in 50% to 70% of fetuses
with trisomy 21. An equally high identification rate is
possible by evaluation of the facial pathology in fetuses
with trisomy 13 and 18. Therefore, cytogenetic evaluation
should be recommended when facial abnormalities are
diagnosed prenatally.
This study confirms that craniofacial abnormalities are
present in a substantial proportion of fetuses with trisomies
21, 18, and 13. Thus, a detailed ultrasonographic evalua-
tion of the fetal cranium and face should be performed in
every fetal anatomical survey, and prenatal diagnosis of
craniofacial abnormalities should prompt consideration of
a karyotype.
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